SK287533B6 - Liečivo na liečenie viacpočetných rezistentných nádorov alebo na inhibíciu angiogenézy a metastáz - Google Patents

Liečivo na liečenie viacpočetných rezistentných nádorov alebo na inhibíciu angiogenézy a metastáz Download PDF

Info

Publication number
SK287533B6
SK287533B6 SK407-2002A SK4072002A SK287533B6 SK 287533 B6 SK287533 B6 SK 287533B6 SK 4072002 A SK4072002 A SK 4072002A SK 287533 B6 SK287533 B6 SK 287533B6
Authority
SK
Slovakia
Prior art keywords
acid
glyoxylamide
indol
pyridin
group
Prior art date
Application number
SK407-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK4072002A3 (en
Inventor
Bernd Nickel
Thomas Klenner
Gerald Bacher
Thomas Beckers
Peter Emig
J�Rgen Engel
Erik Bruyneel
G�Nter Kamp
Kirsten Peters
Original Assignee
Ziopharm Oncology, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19946301A external-priority patent/DE19946301A1/de
Application filed by Ziopharm Oncology, Inc. filed Critical Ziopharm Oncology, Inc.
Publication of SK4072002A3 publication Critical patent/SK4072002A3/sk
Publication of SK287533B6 publication Critical patent/SK287533B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK407-2002A 1999-09-28 2000-09-26 Liečivo na liečenie viacpočetných rezistentných nádorov alebo na inhibíciu angiogenézy a metastáz SK287533B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19946301A DE19946301A1 (de) 1998-04-02 1999-09-28 Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften
PCT/EP2000/009390 WO2001022954A2 (fr) 1999-09-28 2000-09-26 Derives d"acide indolyl-3-glyoxyle a bonnes proprietes therapeutiques

Publications (2)

Publication Number Publication Date
SK4072002A3 SK4072002A3 (en) 2003-11-04
SK287533B6 true SK287533B6 (sk) 2011-01-04

Family

ID=7923485

Family Applications (1)

Application Number Title Priority Date Filing Date
SK407-2002A SK287533B6 (sk) 1999-09-28 2000-09-26 Liečivo na liečenie viacpočetných rezistentných nádorov alebo na inhibíciu angiogenézy a metastáz

Country Status (32)

Country Link
EP (1) EP1218006B1 (fr)
JP (1) JP2003510274A (fr)
KR (1) KR100759242B1 (fr)
CN (1) CN1301712C (fr)
AR (1) AR025885A1 (fr)
AT (1) ATE459356T1 (fr)
AU (1) AU783436B2 (fr)
BG (1) BG106639A (fr)
BR (1) BR0014378A (fr)
CA (1) CA2386069C (fr)
CZ (1) CZ303246B6 (fr)
DE (1) DE50015879D1 (fr)
DZ (1) DZ3196A1 (fr)
EE (1) EE200200169A (fr)
ES (1) ES2342042T3 (fr)
GE (1) GEP20043250B (fr)
HK (1) HK1048941B (fr)
HR (1) HRP20020369A2 (fr)
HU (1) HUP0202788A3 (fr)
IL (2) IL148670A0 (fr)
IS (1) IS6319A (fr)
MX (1) MXPA02002824A (fr)
NO (1) NO322614B1 (fr)
NZ (1) NZ517988A (fr)
PL (1) PL199576B1 (fr)
RS (1) RS51302B (fr)
RU (1) RU2282444C2 (fr)
SK (1) SK287533B6 (fr)
TW (1) TWI269654B (fr)
UA (1) UA75872C2 (fr)
WO (1) WO2001022954A2 (fr)
ZA (1) ZA200202556B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962300A1 (de) * 1999-12-23 2001-06-28 Asta Medica Ag Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung
JP2003535078A (ja) 2000-05-31 2003-11-25 アストラゼネカ アクチボラグ 血管損傷活性のあるインドール誘導体
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
EP1595878A1 (fr) * 2004-05-15 2005-11-16 Zentaris GmbH Derives d'indole destines a l'induction d'apoptose
JP4878285B2 (ja) * 2003-06-05 2012-02-15 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング アポトーシス誘発作用を有するインドール誘導体
EP1484329A1 (fr) * 2003-06-06 2004-12-08 Zentaris GmbH Dérivés d'indole déstinés à l'induction d'apoptose
US20050124623A1 (en) 2003-11-26 2005-06-09 Bender John A. Diazaindole-dicarbonyl-piperazinyl antiviral agents
EP3461813A1 (fr) * 2004-05-23 2019-04-03 Gerard M. Housey Modulateurs de theramuteine
JP2008519036A (ja) * 2004-11-08 2008-06-05 バクスター・インターナショナル・インコーポレイテッド チューブリン阻害化合物のナノ粒子組成物
US20060100432A1 (en) 2004-11-09 2006-05-11 Matiskella John D Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
ES2644450T3 (es) 2004-12-31 2017-11-29 Dr. Reddy's Laboratories Ltd. Nuevos derivados de bencilamina como inhibidores de CETP
US7851476B2 (en) 2005-12-14 2010-12-14 Bristol-Myers Squibb Company Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-YL)-1-[(phosphonooxy)methyl]-1H-pyrrolo[2,3-C]pyridin-3-YL]-1,2-dioxoethyl]-piperazine
US7807671B2 (en) 2006-04-25 2010-10-05 Bristol-Myers Squibb Company Diketo-piperazine and piperidine derivatives as antiviral agents
CA2670778A1 (fr) * 2006-11-28 2008-06-05 Ziopharm Oncology, Inc. Utilisation de derives d'acide indolyl-3-glyoxylique comprenant de l'indibuline, seuls ou combines a d'autres agents, pour traiter le cancer
WO2013024358A2 (fr) 2011-08-18 2013-02-21 Dr. Reddy's Laboratories Ltd. Composés amines hétérocycliques substitués comme inhibiteurs de la protéine de transfert d'ester cholesterylique (cetp)
KR101803866B1 (ko) 2011-09-27 2017-12-04 닥터 레디스 레보러터리즈 리미티드 동맥경화증 치료에 유용한 콜레스테릴 에스테르-전달 단백질(cetp) 억제제로서 5-벤질아미노메틸-6-아미노피라졸로[3,4-b]피리딘 유도체
US9353150B2 (en) 2012-12-04 2016-05-31 Massachusetts Institute Of Technology Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment
CA2905509A1 (fr) 2013-03-15 2014-09-18 Memorial Sloan-Kettering Cancer Center Imagerie cardiaque a ciblage hsp90 et traitement associe
WO2017197045A1 (fr) 2016-05-11 2017-11-16 Movassaghi Mohammad Synthèse totale convergente et énantiosélective d'analogues de la communesine
WO2018209239A1 (fr) 2017-05-11 2018-11-15 Massachusetts Institute Of Technology Dérivés d'agélastatine puissants en tant que modulateurs de l'invasion et de la métastase du cancer
CN109111501B (zh) * 2017-06-23 2022-04-22 首都医科大学 脂肪氨基酸修饰的吲哚乙醇衍生物, 其合成，活性和应用
US10640508B2 (en) 2017-10-13 2020-05-05 Massachusetts Institute Of Technology Diazene directed modular synthesis of compounds with quaternary carbon centers
US11535634B2 (en) 2019-06-05 2022-12-27 Massachusetts Institute Of Technology Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
US12030888B2 (en) 2021-02-24 2024-07-09 Massachusetts Institute Of Technology Himastatin derivatives, and processes of preparation thereof, and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4128089A (en) 1988-09-15 1990-03-22 Rorer International (Overseas) Inc. Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
CA2126217A1 (fr) * 1992-10-20 1994-04-28 Katsuhiro Shibayama Agent pour supprimer l'infiltration d'eosinophiles
DE19636150A1 (de) * 1996-09-06 1998-03-12 Asta Medica Ag N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
AU6523598A (en) 1997-04-08 1998-10-30 Banyu Pharmaceutical Co., Ltd. Cancerous metastasis-associated gene
HUP0101146A3 (en) * 1998-02-25 2001-11-28 Genetics Inst Llc Cambridge Indole derivatives as inhibitors of phospholipase enzymes and pharmaceutical compositions containing them
KR20010041811A (ko) * 1998-03-12 2001-05-25 온토젠 코포레이션 단백질 티로신 포스파타제의 조절제
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
ATE330955T1 (de) * 1998-04-28 2006-07-15 Elbion Ag Indolderivate und deren verwendung als inhibitoren der phosphodiesterase 4.
JP2000239252A (ja) * 1999-02-16 2000-09-05 Mitsubishi Chemicals Corp インドール誘導体
AU4834200A (en) * 1999-05-10 2000-11-21 Protarga, Inc. Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof

Also Published As

Publication number Publication date
YU22702A (sh) 2004-12-31
HRP20020369A2 (en) 2004-12-31
HK1048941A1 (en) 2003-04-25
HK1048941B (zh) 2007-09-21
DZ3196A1 (fr) 2001-04-05
MXPA02002824A (es) 2003-07-21
HUP0202788A2 (hu) 2003-01-28
ATE459356T1 (de) 2010-03-15
NO20021367L (no) 2002-05-22
IL148670A0 (en) 2002-09-12
CA2386069A1 (fr) 2001-04-05
WO2001022954A2 (fr) 2001-04-05
NO322614B1 (no) 2006-11-06
AU7782900A (en) 2001-04-30
ES2342042T3 (es) 2010-07-01
RU2282444C2 (ru) 2006-08-27
AR025885A1 (es) 2002-12-18
PL199576B1 (pl) 2008-10-31
BR0014378A (pt) 2003-07-29
GEP20043250B (en) 2004-06-25
WO2001022954A3 (fr) 2002-03-28
UA75872C2 (en) 2006-06-15
CZ20021005A3 (cs) 2004-01-14
CN1376064A (zh) 2002-10-23
ZA200202556B (en) 2003-08-27
EE200200169A (et) 2003-04-15
KR20030019295A (ko) 2003-03-06
PL364811A1 (en) 2004-12-13
BG106639A (bg) 2002-12-29
CN1301712C (zh) 2007-02-28
DE50015879D1 (de) 2010-04-15
IS6319A (is) 2002-03-21
IL148670A (en) 2009-09-01
SK4072002A3 (en) 2003-11-04
CA2386069C (fr) 2012-08-14
TWI269654B (en) 2007-01-01
NO20021367D0 (no) 2002-03-19
AU783436B2 (en) 2005-10-27
RS51302B (sr) 2010-12-31
EP1218006A2 (fr) 2002-07-03
HUP0202788A3 (en) 2003-02-28
JP2003510274A (ja) 2003-03-18
EP1218006B1 (fr) 2010-03-03
CZ303246B6 (cs) 2012-06-20
NZ517988A (en) 2004-10-29
KR100759242B1 (ko) 2007-09-18

Similar Documents

Publication Publication Date Title
SK287533B6 (sk) Liečivo na liečenie viacpočetných rezistentných nádorov alebo na inhibíciu angiogenézy a metastáz
US20080057124A1 (en) Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
WO2003074045A1 (fr) Agent antitumoral comprenant une combinaison d'un compose heterocyclique contenant un sulfamide et d'un inhibiteur d'angiogenese
EP1415667B1 (fr) Regulateurs de la secretion de suc pancreatique comprenant un agent de regulation du recepteur a lpa
AU2019216351B2 (en) Combination therapy for the treatment of mastocytosis
EP3493848A1 (fr) Diamidines hétérocycliques
AU2015266552A1 (en) Pharmaceutical composition comprising pyrazine carboxamide compound as active ingredient
US20130345231A1 (en) Anticancer therapeutic agents
CZ289533B6 (cs) Pouľití dihydropyridinových derivátů s anelovanými uhlíkovými nebo heterocyklickými kruhy pro výrobu farmaceutických prostředků k ochraně mozkové tkáně
US7358236B1 (en) Control of acute hypertension and cardiotoxicity in patients treated with vascular targeting agents
US20040138207A1 (en) Antitumor agents
US12102620B2 (en) Combination therapy for the treatment of mastocytosis
EP1532978A1 (fr) Medicament agissant sur la frequence de mictions et contre l'incontinence urinaire
US20040048776A1 (en) Medicament for preventive and therapeutic treatment of fibrosis
JP2000086518A (ja) 血管攣縮の予防・治療剤
ITMI962241A1 (it) Uso di derivati tetraidro-beta-carbolinici come agenti antimetastatici
WO2014089450A1 (fr) Inhibiteurs spécifiques de cdk3
WO2003089426A1 (fr) Medicament prophylactique ou therapeutique contre le syndrome de coagulation intravasculaire disseminee

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20140926